Jfs Wealth Advisors, LLC Xencor Inc Transaction History

Jfs Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$18.65 - $26.52 $18 - $26	1 Added 33.33%	4 $0
Q4 2023 Feb 07, 2024	SELL	$16.53 - $21.42 $99 - $128	-6 Reduced 66.67%	3 $0
Q3 2023 Nov 02, 2023	SELL	$20.08 - $25.39 $40 - $50	-2 Reduced 18.18%	9 $0
Q2 2023 Aug 07, 2023	SELL	$24.77 - $29.9 $24 - $29	-1 Reduced 8.33%	11 $0
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $49 - $61	2 Added 20.0%	12 $0
Q3 2022 Oct 21, 2022	BUY	$24.62 - $32.44 $24 - $32	1 Added 11.11%	10 $0
Q2 2022 Aug 02, 2022	BUY	$19.74 - $29.01 $59 - $87	3 Added 50.0%	9 $0
Q1 2022 May 02, 2022	BUY	$26.68 - $41.63 $106 - $166	4 Added 200.0%	6 $0
Q4 2021 Feb 03, 2022	BUY	$33.67 - $43.44 $67 - $86	2 New	2 $0

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.